Engineering avb6-targeted fourth generation chimeric antigen receptor (CAR) T-cells for immunotherapy of pancreaticductal adenocarcinoma (PDAC).

Project: Research

Project Details

StatusFinished
Effective start/end date1/06/201631/05/2018